URBANO, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 732
EU - Europa 324
AS - Asia 138
AF - Africa 4
Totale 1.198
Nazione #
US - Stati Uniti d'America 725
IT - Italia 152
SE - Svezia 75
SG - Singapore 62
IN - India 47
FI - Finlandia 26
DE - Germania 23
CN - Cina 18
BG - Bulgaria 11
GB - Regno Unito 9
CA - Canada 7
FR - Francia 6
UA - Ucraina 6
ID - Indonesia 5
RO - Romania 5
IE - Irlanda 4
TG - Togo 4
EE - Estonia 3
IR - Iran 3
KR - Corea 2
AL - Albania 1
GR - Grecia 1
MK - Macedonia 1
NL - Olanda 1
TR - Turchia 1
Totale 1.198
Città #
Fairfield 109
Chandler 75
Dearborn 49
Woodbridge 47
Ashburn 46
Seattle 46
Singapore 44
Wilmington 42
Houston 36
Cambridge 34
Rome 31
San Paolo di Civitate 23
Helsinki 19
Princeton 19
Ann Arbor 16
Millbury 15
Plano 14
New York 13
Lawrence 11
Siena 11
Sofia 11
Santa Clara 9
Beijing 8
San Diego 8
Caserta 7
Milan 7
Andover 6
Bremen 5
Hyderabad 5
Jakarta 5
Norwalk 5
Boston 4
Dublin 4
Fremont 4
Liverpool 4
Lomé 4
Phoenix 4
Toronto 4
Boardman 3
Leawood 3
Stuttgart 3
Tallinn 3
Bronte 2
Bühl 2
Crispiano 2
Des Moines 2
Falls Church 2
Grafing 2
Islington 2
Mannheim 2
Ottawa 2
Palestrina 2
Velletri 2
Athens 1
Bari 1
Barletta 1
Changsha 1
Chicago 1
Coventry 1
Crema 1
Denver 1
Falkenstein 1
Fiumicino 1
Florence 1
Forlì 1
Gangdong-gu 1
Genoa 1
Gothenburg 1
Hebei 1
Hefei 1
Jacksonville 1
Kunming 1
Lappeenranta 1
Miami 1
Montreal 1
Nanjing 1
Perugia 1
Piediluco 1
Portici 1
Pune 1
Quinto Vicentino 1
Redwood City 1
Romola 1
Sacramento 1
San Mateo 1
Shanghai 1
Shenyang 1
Simi Valley 1
Skopje 1
Stockholm 1
Turin 1
Yongzhou 1
Zanjan 1
Totale 878
Nome #
P-158Radioembolization (SIRT) as a Consolidation Treatment in Colorectal Liver Metastases after First Line Chemotherapy: Efficacy Safety 92
Prolactin as a potential negative predictive factor in metastatic non-small cell lung cancers (NSCLC) patients in treatment with Nivolumab (NIVO) 86
BRAFV600E mutation positive metastatic melanoma in a young woman treated with anti-BRAF/anti MEK combination: a case report 84
Induction chemotherapy followed by neoadjuvant chemoradiotherapy and surgery in locally advanced rectal cancer: preliminary results of a phase II study 84
Evaluation of prognostic factors for survival in transverse colon cancer 82
Adjuvant chemotherapy in resected colon cancer: when, how and how long? 81
Multimodality Treatment of Gynecomastia in Patients Receiving Antiandrogen Therapy for Prostate Cancer in the Era of Abiraterone Acetate and New Antiandrogen Molecules 80
Class 1, 2, and 3 BRAF-mutated metastatic colorectal cancer: a detailed clinical, pathologic, and molecular characterization 79
EGFR inhibitor as second-line therapy in a patient with mutant RAS metastatic colorectal cancer: circulating tumor DNA to personalize treatment 77
E50Safety and toxicity in elderly patients in treatment for metastatic colon cancer 71
Exploratory pilot study of circulating biomarkers in metastatic renal cell carcinoma 71
Clinical and pathological features of primary renal synovial sarcoma: analysis of 64 cases from 11 years of medical literature. 65
Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO 62
Efficacy and tolerability of selective internal radiotherapy with Yttrium-90 as consolidation treatment after chemotherapy in metastatic colorectal cancer 57
Erlotinib in metastatic non-small cell lung cancer (NSCLC) patients unselected for Epidermal Growth Factor Receptors (EGFR) mutations: a retrospective analysis of elderly patients 54
Immunotherapy for colorectal cancer: where are we heading? 52
Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis 51
Long-lasting complete response with trabectedin plu pegylated liposomal doxorubicin (PLD) in a young BRCA-mutated woman with platinum sensitive relapsed ovarian cancer (ROC) : a case report 42
Correction to: Cabozantinib after a previous immune checkpoint inhibitor in metastatic renal cell carcinoma: a retrospective multi-institutional analysis (Targeted Oncology, (2020), 15, 4, (495-501), 10.1007/s11523-020-00732-y) 10
Totale 1.280
Categoria #
all - tutte 4.062
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.062


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020231 0 0 0 0 34 59 32 32 32 23 13 6
2020/2021128 8 10 12 13 15 6 4 8 17 25 7 3
2021/2022235 3 10 12 9 33 15 2 24 14 19 64 30
2022/2023284 44 55 26 19 35 36 1 26 27 3 9 3
2023/2024145 8 23 8 10 13 29 2 24 0 10 13 5
2024/202591 9 8 30 31 13 0 0 0 0 0 0 0
Totale 1.280